Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Source filing unavailable
| Metric | Q1 2014 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Net Income | -$323.65K | -$1.36K | -$1.28K |
| EPS Diluted | -$0.03 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
